Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ulf Schröder is active.

Publication


Featured researches published by Ulf Schröder.


Applied Microbiology and Biotechnology | 1983

A general method for the immobilization of cells with preserved viability

Kjell Nilsson; Staffan Birnbaum; Susanne Flygare; Lotta Linse; Ulf Schröder; Ulla Jeppsson; Per-Olof Larsson; Klaus Mosbach; Peter Brodelius

SummaryMicrobial, algal, plant and animal cells have been immobilized, with preserved viability, by entrapment in various matrices according to a new bead polymerization technique. The cell polymer/monomer mixture is kept suspended in a hydrophobic phase such as soy, paraffin, or silicon oil, tri-n-butylphosphate, or dibutyphtalate, which is compatible with the cells. The various monomers or polymers tested include agarose, agar, carrageenan, alginate, fibrin, and polyacrylamide. Furthermore, by adjustment of the stirring speed of the suspension, beads of desired diameter can easily be obtained. The entrapped cells are fully viable and biosynthetically active.


FEBS Letters | 1979

Preparation and application of magnetic polymers for targeting of drugs.

Klaus Mosbach; Ulf Schröder

There hds been constderable interest during the last few years m the area of drug targeting as it has become clear that m order to achieve optimal condrtrons for the action of pharmacologtcdl agents mteraction with non-target sites should be mmunrzed [ l] Investrgdtrons to complex antrtumour drugs with antibodies are noteworthy m this context [2] Smularly, the use of hposomes as carrters deserves mention as they are predommantly transported mto the liver and spleen [ 1 ] While studying the use of magnetic carriers in affimty chromatography [3] rt occurred to us that magnetrc material might dlso be used as support for drugs which could be brought to the target site wrth the aid of a magnetic field [4] Apart from mmlmrzmg mteractrons with non-target sites such a specific location would allow a high concentration of the drug to be used and would extend the time of exposure at the site In the followmg we wash to report on the preparation and apphcatron of such mdgnetrc drug-carrying materials


Biomaterials | 1984

Crystallized carbohydrate spheres as a slow release matrix for biologically active substances

Ulf Schröder

Described is a novel method of fabrication of crystallized carbohydrate spheres with entrapped substances where it is shown that entrapped peptide hormones such as insulin and interferon, enzymes such as plasmin and beta-galactosidase and monoclonal antibodies retain their biological activity after release from the matrix. In vitro slow release of proteins over several weeks is achieved by erosion of the matrix consisting of carbohydrate polymers such as dextran, dextrins or low molecular weight carbohydrates such as glucose and maltose, all well known biodegradable and biocompatible matrix materials.


Journal of Immunological Methods | 1984

Crystallized dextran nanospheres with entrapped antigen and their use as adjuvants

Ulf Schröder; Arne Ståhl

A novel and simple method is described of preparing a matrix with entrapped antigen, the matrix consisting of well characterized carbohydrates with low toxicity, i.e., dextran and starch, stabilized by crystallization. The crystallized carbohydrate spheres produced probably derive their adjuvant effect from slow antigen release and macrophage stimulation. Five months after a single injection of 80 micrograms ovalbumin entrapped in dextran spheres, mice produced antibodies against ovalbumin and this response could be enhanced further by co-entrapment of immunomodulators such as DEAE- or SO4-dextrans into the spheres. A single injection of 8 micrograms entrapped bee venom into mice gave the same IgG antibody response as 2 X 80 micrograms bee venom dissolved in water. By the same method it was possible to inject 4 times the LD50 dose of entrapped bee venom in mice without any significant side reactions.


Journal of Immunological Methods | 1986

Magnetic carbohydrate nanoparticles for affinity cell separation.

Ulf Schröder; Sverker Segrén; Charlotte Gemmefors; Gunnar Hedlund; Bo Jansson; Hans-Olov Sjögren; Carl Borrebaeck

Magnetically responsive nanoparticles were prepared from enzymatically hydrolysed starch and magnetite. Two different monoclonal antibodies were covalently coupled to the particles. The antibody-coupled particles were in the size range of 100-300 nm and had an iron content of about 60%. Using 100 micrograms of magnetic particles (coupled with monoclonal mouse anti-rat Ig kappa light chain antibody) a very high depletion of surface Ig positive cells (mostly B-cells) from one million rat peripheral blood mononuclear cells could be achieved. The separation efficiency was evaluated by flow cytofluorometric analysis. This technique permits the detection of a small number of surface Ig positive cells among 10,000 negative cells.


Applied Biochemistry and Biotechnology | 1982

Magnetic microspheres for targeting of drugs

Ulf Schröder; Klaus Mosbach

Magnetic microspheres were prepared from starch. The microspheres could be crosslinked with various agents, and drugs could be entrapped adsorbed, or covalently coupled to the microspheres.


Archive | 1982

Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof

Ulf Schröder; Klaus Mosbach


Magnetic Resonance Imaging | 1986

Ferromagnetic particles as contrast agent in T2 NMR imaging

Magnus B.E. Olsson; Bertil Persson; Leif G. Salford; Ulf Schröder


Archive | 1983

Magnetic carbohydrate particles as carriers for affinity separation purposes, e.g. cell separation

Carl Borrebaeck; Ulf Schröder


Magnetic Resonance Imaging | 1986

Super-paramagnetic particles as T2 contrast agent in proton MR-imaging

Magnus Olsson; Bertil Persson; Leif G. Salford; Ulf Schröder

Collaboration


Dive into the Ulf Schröder's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge